Nelfinavir

VIRACEPT®

Overview

Nelfinavir is an orally admin­istered drug that belongs to a treatment classification called protease inhibitors. Preclinical data suggests that Nelfinavir may overcome resistance to proteasome inhibitors in multiple myeloma.

SparkCures ID 323
Brand Name Viracept®
Generic Name Nelfinavir
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources